Good Market Launches No-Code Trading Platform to Address Retail Traders’ $2.1 Trillion Challenge

London, London, January 14th, 2025, Chainwire

Good Market, built by fintech veterans from M2 Exchange and Freetrade, introduces a new trading platform that combines AI-driven trading with human-centered design. The platform enters closed beta testing with an initial group of 500+ traders, targeting a significant reduction in emotional trading errors – a key factor in the well-documented 90-95% failure rate among retail traders.

The platform streamlines complex trading processes through systematic execution and automated risk management, addressing key issues that typically lead to trading losses.

“Current trading platforms are part of the problem, not the solution,” says Good Market’s development team. “While Binance, Coinbase, and other exchanges focus on transaction volume, they’ve neglected the fundamental issue: traders lack systematic execution tools that prevent emotional trading and enforce disciplined strategies.”

Demo: Good Markets platform

Good Market’s Smart Assist Intelligence™ tackles this crisis head-on by automating trade execution and risk management. The platform allows traders to configure up to 300+ parameters, including technical indicators and entry/exit conditions, without writing code. This systematic approach eliminates the psychological biases that plague manual trading of popular tokens like Polygon (MATIC), Chainlink (LINK), and Avalanche (AVAX).

Core Platform Features:

AI-assisted analysis with semi-auto or fully automated execution
AI-prompted strategy builder with 300+ parameters (no coding required)
Automated position sizing and risk controls
A community marketplace for verified strategies
Integrated technical and fundamental analysis

Getting $GOOD

The platform’s native token, $GOOD, offers practical benefits including trading fee reductions of up to 20% and access to premium features. The initial token sale begins at $0.025, with 4 million tokens available in Phase 1 before moving to $0.05 in Phase 2.

Early Investor Benefits: